Details for 2020764910

Up to date per 02.04.2026

Actions

Title / Product Name

VMAT2-HEMMER VALBENAZIN ZUR VERWENDUNG IN EINEM VERFAHREN ZUR BEHANDLUNG EINER NEUROLOGISCHEN ODER PSYCHIATRISCHEN STÖRUNG BEI PATIENTEN MIT STARKER NIERENSCHÄDIGUNG

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2020764910

EP Publication Number

4017494

E-Number

1826587

Language

PCT Number

US20047392

Publication Date

29.06.2022 A

20.08.2025 B1

Registration Date

20.08.2025

AT Publication Date

15.09.2025

Application Date

21.08.2020

Registration Number

Priorities

23.08.2019

201962890697 P

22.05.2020

202063028754 P

IPC

A61K 31/4738 20060101AFI20210305BHEP

Maximum Duration of Protection

21.08.2040

Owner

Neurocrine Biosciences, Inc.6027 Edgewood Bend Court San Diego, CA 92130US

Representative

No representatives present

Inventor

LOEWEN, Gordon Raphael229 N. Granados Ave. Solana Beach, California 92075US

LUO, Sha Rosa12780 El Camino Real San Diego, California 92130US

Information about Fees